Sai Life Sciences Limited has informed the Exchange about Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2025
SAILIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sai Life Sciences has submitted a quarterly compliance certificate to BSE and NSE as required under Regulation 74(5) of SEBI's Depositories and Participants Regulations, 2018. The certificate, dated July 3, 2025, was issued by KFin Technologies, the company's Registrar and Share Transfer Agent. It confirms that details of shares that were dematerialized (converted to electronic form) or rematerialized (converted back to physical form) during the quarter ended June 30, 2025 have been furnished to both stock exchanges where the company is listed (BSE scrip code 544306, NSE symbol SAILIFE). The letter was signed by Runa Karan, Company Secretary & Compliance Officer, on July 14, 2025.
This is a routine, procedural regulatory filing required of all listed companies every quarter. It has no impact on the company's business, financials, or stock price — it simply confirms that share movement records have been properly reported to the exchanges and depositories.